FibroBiologics, Inc.
FBLG
$0.8762
$0.00120.14%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.16M | -17.78M | -19.47M | -22.53M | -16.49M |
| Total Depreciation and Amortization | 573.00K | 550.00K | 519.00K | 478.00K | 437.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 3.00K | 81.00K |
| Total Other Non-Cash Items | -1.87M | 5.64M | 8.29M | 12.24M | 9.07M |
| Change in Net Operating Assets | 559.00K | 1.16M | 1.70M | 1.17M | 493.00K |
| Cash from Operations | -11.90M | -10.43M | -8.96M | -8.64M | -6.40M |
| Capital Expenditure | -184.00K | -87.00K | -489.00K | -447.00K | -495.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -184.00K | -87.00K | -489.00K | -447.00K | -495.00K |
| Total Debt Issued | 9.97M | 574.00K | 574.00K | 574.00K | -- |
| Total Debt Repaid | -574.00K | -459.00K | -287.00K | -115.00K | -- |
| Issuance of Common Stock | 7.51M | 7.46M | 2.82M | 2.82M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 940.00K | 11.25M | 16.14M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -12.02M | -2.35M |
| Cash from Financing | 16.91M | 7.58M | 4.05M | 2.51M | 13.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.82M | -2.94M | -5.41M | -6.58M | 6.90M |
